Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 2Active not recruiting 2

Sponsor Class

OTHER 4

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 3

Conditions

Neoplasms 4Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Hematologic Neoplasms 1Depression 1Death 1Cancer Patients 1Acquired Immunodeficiency Syndrome 1

Interventions

pembrolizumab 38Bevacizumab 23Cyclophosphamide 22Standard of Care 18Blood Specimen Collection 17Carboplatin 16Paclitaxel 15Nivolumab 14Gemcitabine 14Pemetrexed 13Exercise 13Cisplatin 12atezolizumab 11Radiotherapy 11Fluorouracil 11Doxorubicin 11Surveys and Questionnaires 9Rituximab 9Oxaliplatin 9Magnetic Resonance Spectroscopy 9Leucovorin 9Cetuximab 9Biopsy 9130-nm albumin-bound paclitaxel 9durvalumab 8abemaciclib 8Docetaxel 8olaparib 7Temozolomide 7Prednisone 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Neoplasms × Focus Groups × 90 days × Clear all
NCT06786104 2026-05-14

VIDEO-PEDS

Massachusetts General Hospital

Phase NA Recruiting
567 enrolled

Death, Neoplasms

NCT06549153 2026-03-09

ACT-Together (Acting on Cancer Testing-Together)

M.D. Anderson Cancer Center

Phase NA Active not recruiting
30 enrolled
Tumor-Agnostic

Neoplasms

NCT00832325 2026-03-03

Adolescent and Young Adult Cancer Survivors: Identity Development

Memorial Sloan Kettering Cancer Center

Active not recruiting
300 enrolled
Tumor-Agnostic

Neoplasms

NCT05694650 2026-03-03

Perceptions of Hospital Care at Home for Patients With Cancer: A Qualitative Study of Cancer Providers, Patients and Caregivers.

M.D. Anderson Cancer Center

Recruiting
20 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡